Naoki Kubota

610 total citations
38 papers, 417 citations indexed

About

Naoki Kubota is a scholar working on Surgery, Experimental and Cognitive Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Naoki Kubota has authored 38 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Experimental and Cognitive Psychology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Naoki Kubota's work include Sleep and related disorders (13 papers), Sleep and Wakefulness Research (10 papers) and Circadian rhythm and melatonin (5 papers). Naoki Kubota is often cited by papers focused on Sleep and related disorders (13 papers), Sleep and Wakefulness Research (10 papers) and Circadian rhythm and melatonin (5 papers). Naoki Kubota collaborates with scholars based in Japan, United States and United Kingdom. Naoki Kubota's co-authors include Margaret Moline, Gleb Filippov, Yuichi Inoue, Kohei Ishikawa, Jane Yardley, Mikko Kärppä, Carlos Perdomo, Kate Pinner, Kunihiro Hattori and Tatsumi Yamazaki and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Naoki Kubota

31 papers receiving 408 citations

Peers

Naoki Kubota
Giulia De Conti Netherlands
Dyan Sellayah United Kingdom
Dinah Faith T. Quiton United States
M Giroud France
Julia Kempf United States
Marie Pariollaud United States
Naoki Kubota
Citations per year, relative to Naoki Kubota Naoki Kubota (= 1×) peers Machiko Kiyokawa

Countries citing papers authored by Naoki Kubota

Since Specialization
Citations

This map shows the geographic impact of Naoki Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Kubota more than expected).

Fields of papers citing papers by Naoki Kubota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Kubota. The network helps show where Naoki Kubota may publish in the future.

Co-authorship network of co-authors of Naoki Kubota

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Kubota. A scholar is included among the top collaborators of Naoki Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Kubota. Naoki Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krystal, Andrew D., Pierre Blier, Larry Culpepper, et al.. (2024). Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms. Neuropsychopharmacology Reports. 45(1). e12509–e12509. 2 indexed citations
2.
Ozaki, Kazuyuki, Ryutaro Ikegami, Naoki Kubota, et al.. (2024). Pd/Pa fluctuation with continuous ATP administration indicates inaccurate FFR measurement caused by insufficient hyperemia. Heart and Vessels. 40(1). 8–15. 1 indexed citations
4.
Kubota, Naoki, et al.. (2023). Angioscopic Findings of Calcification in Saphenous Vein Graft. Circulation Journal. 87(11). 1705–1705.
5.
Ozaki, Kazuyuki, Naoki Kubota, Takeshi Okubo, et al.. (2023). Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Treatment for Repeated In-stent Restenosis in a Coronary Artery. Internal Medicine. 62(22). 3361–3365. 1 indexed citations
6.
Ozaki, Kazuyuki, et al.. (2023). Left Main Coronary Artery Compression Syndrome Caused by Chronic Mitral Valve Disease. Circulation Journal. 87(3). 467–467.
7.
Inoue, Yuichi, Naoki Kubota, Michinori Koebis, et al.. (2022). Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings. Journal of Clinical Sleep Medicine. 19(3). 519–528. 10 indexed citations
8.
Dash, Amitabh, Kate Pinner, Yuichi Inoue, et al.. (2022). Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder. SHILAP Revista de lepidopterología. 4. 100044–100044. 4 indexed citations
9.
Ozaki, Kazuyuki, Ryutaro Ikegami, Naoki Kubota, et al.. (2021). Conservative treatment with an intra-aortic balloon pump to treat acute myocardial infarction due to spontaneous coronary artery dissection. Journal of Cardiology Cases. 23(6). 274–280. 2 indexed citations
10.
Ozaki, Kazuyuki, Takeshi Okubo, Naoki Kubota, et al.. (2021). Unstable angina complicated with dynamic left ventricular outflow tract obstruction. Journal of Cardiology Cases. 23(4). 181–188. 3 indexed citations
11.
Inoue, Yuichi, Takeshi Watanabe, Kohei Ishikawa, et al.. (2021). Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study. Journal of Clinical Sleep Medicine. 17(5). 1067–1074. 6 indexed citations
12.
Moline, Margaret, Stephen Thein, Mohammad Bsharat, et al.. (2021). Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial. The Journal of Prevention of Alzheimer s Disease. 8(1). 7–18. 31 indexed citations
13.
Ozaki, Kazuyuki, et al.. (2021). Angioscopic findings of a first-generation drug-eluting stent occurring very late stent thrombosis 13 years after implantation. Cardiovascular Intervention and Therapeutics. 37(2). 395–396.
14.
Kishi, Taro, Michinori Koebis, Kenzo Muramoto, et al.. (2021). Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review. Neuropsychopharmacology Reports. 41(4). 450–458. 21 indexed citations
15.
Yardley, Jane, Mikko Kärppä, Yuichi Inoue, et al.. (2021). Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial. Sleep Medicine. 80. 333–342. 53 indexed citations
16.
17.
Watanabe, Masao, Yu Nakamura, Yasumasa Yoshiyama, et al.. (2019). Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo‐controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 398–408. 4 indexed citations
18.
Thein, Stephen, et al.. (2019). F1‐06‐04: RESPONSE TO TREATMENT WITH LEMBOREXANT: SUBJECTS WITH IRREGULAR SLEEP‐WAKE RHYTHM DISORDER AND ALZHEIMER'S DISEASE DEMENTIA. Alzheimer s & Dementia. 15(7S_Part_3). 4 indexed citations
19.
Yardley, Jane, Mikko Kärppä, Yuichi Inoue, et al.. (2019). Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: 12-month results from sunrise-2. Sleep Medicine. 64. S263–S264. 3 indexed citations
20.
Kubota, Naoki, et al.. (1990). Structural Characterization of Natural and Recombinant Human Granulocyte Colony-Stimulating Factors1. The Journal of Biochemistry. 107(3). 486–492. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026